{"id":49703,"date":"2022-10-17T18:02:03","date_gmt":"2022-10-17T16:02:03","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/"},"modified":"2022-10-17T18:02:03","modified_gmt":"2022-10-17T16:02:03","slug":"pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/","title":{"rendered":"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology."},"content":{"rendered":"
\n

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)–#Europe<\/a>—AESARA<\/a> is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access.\n<\/p>\n

<\/a><\/p>\n

\n“Rohit brings a wealth of oncology Market Access and Health Economics and Outcomes Research (HEOR) experience that will provide an infusion of critical subject matter expertise to AESARA\u2019s growing presence in oncology globally,” says Sissi Pham, CEO of AESARA\n<\/p>\n

\nWith over 20 years in the pharmaceutical industry, Rohit\u2019s experiences span across multiple RWE initiatives assessing and quantifying value and economics of precision medicine, including Next Generation Sequencing (NGS) and across different tumors in variety of clinical practice settings. Rohit has completed multiple Value Based Pricing (VBP) initiatives and HTA models to influence drug pricing at C-Suite levels, Outcomes- and Value-based Contracts (OBC\/VBC) with multiple organized payer systems. He has also recently developed innovative strategy and tactics for US HTAs including ICER.\n<\/p>\n

\nChad Patel, US Strategic Partnerships Head added, \u201cAESARA\u2019s Oncology vision is very much aligned with Rohit\u2019s career aspirations to build our Oncology Center of Excellence customized on our clients\u2019 needs in bringing innovative oncology assets to more patients that is grounded in evidence and with our value and access strategic thinking.\u201d\n<\/p>\n

\nAbout AESARA<\/b>\n<\/p>\n

\nAESARA is a market access agency with a focused purpose to impact healthcare decision-making to improve people\u2019s lives. Established in 2016, we are a woman and minority-owned company with biopharma seasoned industry professionals in the U.S., Canada, and Europe. Our diverse team is passionate about delivering to our client\u2019s transformative market access strategies and innovative digital communication solutions. For more information, please visit www.aesara.com<\/a> and connect with AESARA on Twitter<\/a> and LinkedIn<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPam Read
\n
+1 587 233 4260 \/ pam@aesara.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)–#Europe—AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access. “Rohit brings a wealth of oncology Market Access and Health Economics and Outcomes Research … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49703","6":"format-standard","7":"category-industry"},"yoast_head":"\nPharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology. - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology. - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)–#Europe—AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access. “Rohit brings a wealth of oncology Market Access and Health Economics and Outcomes Research ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-17T16:02:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221017005707\/en\/1603925\/21\/AESARA_logo_V1%404x.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology.\",\"datePublished\":\"2022-10-17T16:02:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/\"},\"wordCount\":317,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005707\\\/en\\\/1603925\\\/21\\\/AESARA_logo_V1%404x.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/\",\"name\":\"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology. - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005707\\\/en\\\/1603925\\\/21\\\/AESARA_logo_V1%404x.jpg\",\"datePublished\":\"2022-10-17T16:02:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005707\\\/en\\\/1603925\\\/21\\\/AESARA_logo_V1%404x.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221017005707\\\/en\\\/1603925\\\/21\\\/AESARA_logo_V1%404x.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology. - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/","og_locale":"en_US","og_type":"article","og_title":"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology. - Pharma Trend","og_description":"CHAPEL HILL, N.C. & TORONTO & LONDON & ZUG, Switzerland–(BUSINESS WIRE)–#Europe—AESARA is pleased to announce the appointment of Rohit Borker as VP, Oncology, at AESARA, a digital-forward market access agency that develops innovative and trusted solutions to power transformative market access. “Rohit brings a wealth of oncology Market Access and Health Economics and Outcomes Research ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-17T16:02:03+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221017005707\/en\/1603925\/21\/AESARA_logo_V1%404x.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology.","datePublished":"2022-10-17T16:02:03+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/"},"wordCount":317,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221017005707\/en\/1603925\/21\/AESARA_logo_V1%404x.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/","url":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/","name":"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology. - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221017005707\/en\/1603925\/21\/AESARA_logo_V1%404x.jpg","datePublished":"2022-10-17T16:02:03+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221017005707\/en\/1603925\/21\/AESARA_logo_V1%404x.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221017005707\/en\/1603925\/21\/AESARA_logo_V1%404x.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/pharmaceutical-industry-oncology-veteran-rohit-borker-to-join-aesara-as-vp-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Pharmaceutical Industry Oncology Veteran Rohit Borker to join AESARA as VP, Oncology."}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49703","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49703"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49703\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49703"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49703"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49703"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}